Ligand validation:3EC0

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3EC0_IMD_B_301	92%	66%	0.087	0.979	0.34	0.97	-	-	0	0	100%	1
3EC0_IMD_B_303	44%	70%	0.18	0.906	0.25	0.9	-	-	0	0	100%	0.6
3EC0_IMD_B_302	37%	77%	0.183	0.88	0.29	0.61	-	-	0	0	100%	1
3EC0_IMD_B_305	32%	76%	0.221	0.896	0.21	0.72	-	-	0	0	100%	0.5
3EC0_IMD_A_306	8%	74%	0.285	0.765	0.15	0.83	-	-	3	0	100%	0.5
3EC0_IMD_A_304	7%	70%	0.278	0.742	0.21	0.91	-	-	0	0	100%	0.5
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1
3NN1_IMD_B_243	99%	76%	0.049	0.986	0.35	0.59	-	-	0	0	100%	1
2ASN_IMD_X_202	99%	67%	0.051	0.987	0.4	0.87	-	-	1	0	100%	1
3EBZ_IMD_B_301	99%	63%	0.059	0.99	0.35	1.03	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.